BRCA2 and breast carcinoma: ISG15-mediated fork protection is beneficial to cancer cells; indeed, the sole upregulation of ISG15 increases resistance of BRCA2-deficient mouse breast cancer cells to platinum-derived chemotherapeutic agents.